# RETACRIT

NDC: 59353-010
Generic name: epoetin alfa-epbx
Labeler / Manufacturer: Vifor (International) Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS, SUBCUTANEOUS
Marketing started: 20180618

FDA application: BLA125545

## Active ingredients

- EPOETIN: 10000 [iU]/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"59353-010"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=59353-010
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e6e4dd0c-25ca-40b2-ba6b-6138a68621fe